TITLE

An intranasal influenza vaccine for the prevention of influenza in healthy children was cost-effective

AUTHOR(S)
Schwartz, Ben
PUB. DATE
March 2002
SOURCE
ACP Journal Club;Mar/Apr2002, Vol. 136 Issue 2, p75
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Presents information on a study which assessed the cost-effectiveness of an intranasal influenza vaccine for the prevention of influenza in healthy children. Methodology of the study; Results; Comments on the study.
ACCESSION #
8907218

 

Related Articles

  • Intranasal vaccine for prevention of influenza in children. Hartzema, Abraham C. // American Journal of Health-System Pharmacy;8/15/2004, Vol. 61 Issue 16, p1716 

    Assesses the use of the FluMist live attenuated intranasal vaccine to prevent childhood influenza in the U.S. Clinical trials of intranasal influenza vaccines; Requirements for an efficient and effective use of FluMist; Role of pharmacists in influenza immunization.

  • Childhood influenza vax cost effective in England and Wales.  // PharmacoEconomics & Outcomes News;1/19/2013, Issue 670, p4 

    The article discusses research on the cost-effectiveness of childhood influenza vaccination in England and Wales, referencing a study by R. J. Pitman and colleagues published in the December 13, 2012 issue of "Vaccine."

  • School-located influenza vaccination worth a shot.  // PharmacoEconomics & Outcomes News;4/1/2013, Issue 675, p5 

    An abstract of the article "Cost effectiveness analysis of elementary school-located vaccination against influenza-Results from a randomized controlled trial," by B. K. Yoo and colleagues is presented.

  • Seasonal Influenza Vaccination for Children in Thailand: A Cost-Effectiveness Analysis. Meeyai, Aronrag; Praditsitthikorn, Naiyana; Kotirum, Surachai; Kulpeng, Wantanee; Putthasri, Weerasak; Cooper, Ben S.; Teerawattananon, Yot // PLoS Medicine;May2015, Vol. 12 Issue 5, p1 

    Background: Seasonal influenza is a major cause of mortality worldwide. Routine immunization of children has the potential to reduce this mortality through both direct and indirect protection, but has not been adopted by any low- or middle-income countries. We developed a framework to evaluate...

  • Health benefits, risks, and cost-effectiveness of influenza vaccination of children. Prosser, Lisa A.; Buxton Bridges, Carolyn; Uyeki, Timothy M.; Hinrichsen, Virginia L.; Meltzer, Martin I.; Molinari, Noelle-Angelique M.; Schwartz, Benjamin; Thompson, William W.; Fukuda, Keiji; Lieu, Tracy A.; Bridges, Carolyn Buxton // Emerging Infectious Diseases;Oct2006, Vol. 12 Issue 10, p1548 

    We estimated cost-effectiveness of annually vaccinating children not at high risk with inactivated influenza vaccine (IIV) to range from US $12,000 per quality-adjusted life year (QALY) saved for children ages 6-23 months to $119,000 per QALY saved for children ages 12-17 years. For children at...

  • Nasal Spray Vaccine Prevents Flu and Ear Infections.  // USA Today Magazine;Oct98, Vol. 127 Issue 2641, p3 

    Reports that researchers have discovered that a nasal spray vaccine prevents the flu in children and has proven highly effective in preventing ear infection. Advantages of the nasal spray vaccine; Features of the vaccine.

  • Drugs in the News.  // Clarendon Enterprise (TX);3/8/2007, Vol. 18 Issue 12, p8 

    The article reports on the results of a study suggesting that intranasal flu vaccine is superior to flu shot in children.

  • Trivalent influenza vaccine well tolerated among healthy infants.  // Infectious Diseases in Children;Apr2008, Vol. 21 Issue 4, p28 

    The article discusses research which found that trivalent cold-adapted influenza vaccine (CAIV-T) is generally well tolerated among healthy infants aged 6 to 24 weeks. It references a study published in "Pediatrics." The CAIV-T was administered intranasally to healthy infants aged 6 to 24 weeks....

  • Intranasal Administration of Influenza Vaccines: Current Status. Eyles, J.E.; Williamson, E.D.; Alpar, H.O. // BioDrugs;2000, Vol. 13 Issue 1, p35 

    This review article focuses on intranasal immunisation against influenza, although it also encompasses antigen uptake and processing in the nasopharyngeal passages, host defence from influenza and current influenza vaccination practices. Improvement of current vaccination strategies is clearly...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics